STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. VYNE
  4. [ARS] VYNE Therapeutics Inc. SEC Filing

[ARS] VYNE Therapeutics Inc. SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - VYNE Therapeutics Inc.

ARS Filing - VYNE Therapeutics Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: VYNE Therapeutics Inc. (VYNE)

Acceptance Date: 2025-11-12T16:13:01.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock VYNE logo
Vyne Therapeutics Inc

NASDAQ:VYNE

VYNE Rankings

#6163 Ranked by Market Cap
N/A Ranked by Dividends

VYNE Latest News

Nov 6, 2025
VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update
Aug 14, 2025
VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update
Jul 30, 2025
VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo
Jul 2, 2025
VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202
May 8, 2025
VYNE Therapeutics Reports 2025 First Quarter Financial Results and Provides Business Update

VYNE Latest SEC Filings

Nov 6, 2025
[10-Q] VYNE Therapeutics Inc. Quarterly Earnings Report
Nov 6, 2025
[8-K] VYNE Therapeutics Inc. Reports Material Event
Oct 2, 2025
[Form 4] VYNE Therapeutics Inc. Insider Trading Activity
Oct 2, 2025
[Form 4] VYNE Therapeutics Inc. Insider Trading Activity
Aug 14, 2025
[SCHEDULE 13G/A] VYNE Therapeutics Inc. SEC Filing

VYNE Stock Data

12.27M
31.73M
5.38%
34.53%
5.25%
Biotechnology
Pharmaceutical Preparations
Link
United States
BRIDGEWATER